Margaretta Colangelo

Margaretta Colangelo is Co-founder and CEO of Jthereum an enterprise Blockchain company and President of U1 Technologies an enterprise software company. She has published over 300 articles on AI and DeepTech. Margaretta serves on the advisory board of the AI Precision Health Institute at the University of Hawaii Cancer Center. She is based in San Francisco.

 

Insilico Medicine Initiates Trial – Doses First Human With AI-Discovered Drug

Insilico Medicine announced today that they have started the first human trial of ISM001-055 their AI-designed drug candidate for pulmonary fibrosis. This is a very significant milestone in the history of AI-powered drug discovery because this is the first time that a human being has been dosed with an AI-discovered novel molecule based on an […]

Insilico Medicine Initiates Trial – Doses First Human With AI-Discovered Drug Read More »

Scientists Develop AI Algorithms To Analyze Enormous Datasets In Alzheimer’s Research

Leucadia Therapeutics has developed AI algorithms that allow neuroscientists to analyze enormous datasets. This new approach incorporates cutting-edge deep learning applied to an advanced method for ultra-resolution contrast-enhanced micro-CT, a novel animal model, and a large clinical study designed to produce highly curated data for machine learning. For the past 25 years, Alzheimer’s disease researchers

Scientists Develop AI Algorithms To Analyze Enormous Datasets In Alzheimer’s Research Read More »

FDA Grants Approval For AI-Based Pathology Product For The First Time

This landmark approval of Paige Prostate by the FDA marks the beginning of a new era in the use of AI in pathology and paves the way for new innovations using AI in diagnostics. This week in a historic milestone, the FDA approved the first ever AI-based pathology product approved for clinical use. Paige Prostate is the first

FDA Grants Approval For AI-Based Pathology Product For The First Time Read More »

Deep Learning Improves Prediction and Detection of Malignant Breast Cancer

Exciting new research from the AI Precision Health Institute at UH Cancer Center shows that deep learning can distinguish between mammograms of women who will develop breast cancer and those who will not. X-rays were first used to detect breast cancer in 1913. Although breast imaging has evolved, the fundamental information that radiologists use to

Deep Learning Improves Prediction and Detection of Malignant Breast Cancer Read More »

Scroll to Top